Biomarker values of NT-proBNP and hs-cTnI were significantly higher among MI+ than MI– patients (5,227 (3,079–12,004) versus 2,286 (1,110–5,976) pg/mL, p = 0.008 and 35.8 (19.3–84.2) versus 16.0 (10.0–27.3) ng/L, p = 0.001, respectively). This evidence concerns the gene TNNI3 and myocardial infarction.